Atorvastatin News and Research

RSS
Celera receives patent on KIF6 gene variant

Celera receives patent on KIF6 gene variant

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Study determines dose-specific patterns associated with generic statin switching

Study determines dose-specific patterns associated with generic statin switching

Celera Corporation releases review article on KIF6 gene variant for CHD

Celera Corporation releases review article on KIF6 gene variant for CHD

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Pfizer's new chewable Lipitor for children receives European Commission approval

Pfizer's new chewable Lipitor for children receives European Commission approval

European Congress of Nephrology unveils results of various clinical trials

European Congress of Nephrology unveils results of various clinical trials

Anthera commences enrollment in pivotal VISTA-16 Phase 3 clinical study of varespladib

Anthera commences enrollment in pivotal VISTA-16 Phase 3 clinical study of varespladib

LIVALO for primary hyperlipidemia or mixed dyslipidemia now available in U.S.

LIVALO for primary hyperlipidemia or mixed dyslipidemia now available in U.S.

Celera applies CE mark to real-time PCR test for detection of variant in KIF6 gene

Celera applies CE mark to real-time PCR test for detection of variant in KIF6 gene

Volcano to highlight extensive pipeline of imaging and therapy products at EuroPCR 2010

Volcano to highlight extensive pipeline of imaging and therapy products at EuroPCR 2010

Apotex launches generic Lipitor

Apotex launches generic Lipitor

Cobalt Pharmaceuticals receives Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets

Cobalt Pharmaceuticals receives Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets

SNP biomarker could reduce guesswork associated with prescribing drugs

SNP biomarker could reduce guesswork associated with prescribing drugs

Study: Atorvastatin may slow down MS progression

Study: Atorvastatin may slow down MS progression

Results of research study on the expression of KIF6 in mouse model

Results of research study on the expression of KIF6 in mouse model

Pravastatin benefits elderly carriers of KIF6 gene variant with prior vascular disease

Pravastatin benefits elderly carriers of KIF6 gene variant with prior vascular disease

Almost 62% of Canadians age 65 and older use five or more classes of prescription drugs: CIHI study

Almost 62% of Canadians age 65 and older use five or more classes of prescription drugs: CIHI study

Lipitor 80 mg may help reduce risk of major cardiovascular events in high-risk patients

Lipitor 80 mg may help reduce risk of major cardiovascular events in high-risk patients

Sigma-Aldrich and Pfizer sign new agreement

Sigma-Aldrich and Pfizer sign new agreement